* Note: Prices are in Million (M) USD.
Description:
Health Catalyst, Inc. (HCAT) is a leading provider of innovative data and analytics solutions tailored for healthcare organizations, aimed at improving operational efficiencies and enhancing patient outcomes. Headquartered in South Jordan, Utah, the company employs a robust data platform coupled with advanced analytics to empower healthcare professionals with evidence-based decision-making tools across various settings. Positioned at the forefront of the burgeoning healthcare analytics market, Health Catalyst is uniquely equipped to meet the escalating demand for sophisticated analytical solutions in an industry increasingly focused on data-driven care delivery and improved quality outcomes.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $0 M
Debt : $0 M
EBITDA : $-33 M
Since Ebitda is less than 0, 0 points assigned.
This criteria used industry in which company operates:
Sector: Health care
Industry: Health information services
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Message: Invalid quote data provided.
Using default values for calculation.
Forward PE Ratio (using default values): 20.00
Since Forward PE Ratio is between 20 - 25, 2 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Using last 8 overlapping fiscal years (max 20).Average Free Cash Flow: $-37 M
Average Revenue: $206 M
Revenue Converted To Free Cash Flow (%): -18.2%
Since Free Cash Flow (FCF) to Revenue percentage is non-positive, 0 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $307 M
Revenue 5 Years Ago (2019-12-31): $155 M
Total Growth over 5 Years: 97.9%
5-Year Revenue CAGR (Historical): 14.6%
Forward 5-Year CAGR (Tapered): 11.7%
Since historical Revenue CAGR is between 10 - 15, 3 points assigned.
This criteria used Company's ability to buy back its own share:
Error: Invalid balance sheet data provided.Using default values for calculation.
Based on default values, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $0.35
Trailing 12-Month Earnings Per Share (EPS): $0.21
Average Earnings Per Share (EPS): $0.28
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0.00%
Since Dividend Per Share is less than or equal to 0, 0 point assigned.
Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Error: Invalid balance sheet data provided.Skipping ROE-based PE.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Error: Invalid quote data provided.Using default values for calculation.
Based on default values, 0 points assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $166 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Message: Invalid quote data provided.Using default recommendation.
Based on the calculated score, we don't recommend any investment in this stock.
Warren Buffett's Owners' Earnings:
No positive free cash flow found (TTM or annual) to compute Owners' Earnings per share.
Note: Many fast-growing companies reinvest heavily, so Owners' Earnings may appear low.
Consider other factors in your valuation.
Value-Trade has assigned 9 points to above Health Catalyst Inc (HCAT) stock.
Last 1 Years Avg PE
25.25, Fair Value PE
9, Industry Based PE
20, Growth Based PE
15, Risk-Free Anchored PE (25% MoS)
18.34. Based on these 5 values, average assigned is
17.52. Value-Trades has assined P/E value
17.50. An average (Current Year EPS + Next Year EPS) earning per share is
$0.28.
Fair value using multiple P/Es (blended): $4.90 (PE 17.52 × EPS $0.28)
So the Final Fair Value is: $4.90
Understanding the Value-Trades P/E Blend (click to expand)
▾
What goes into the blended P/E?
- 20-Year Avg P/E — Long-run market baseline; conservative anchor.
- Fair Value P/E — Score-based (cash, debt, sector, etc.).
- Industry P/E — Peer group norm.
- Growth-Based P/E — Uses tapered growth rates, floored at 15.
- RCFC-Based P/E — Maps cash conversion efficiency.
- ROE-Based P/E — Higher ROE supports higher multiples.
- Risk-Free Anchored P/E — Macro floor tied to 10y yield w/ MoS.
How it works
- Extreme values are clamped/filtered (IQR method).
- Anchors (20y avg, RCFC/ROE, risk-free) are always kept if valid.
- Final fair value = min(Blended PE × EPS, Avg PE × EPS).
P/E Reference Summary
Using EPS: $0.28
| Source |
P/E Ratio |
Implied Fair Value |
| Market (1 Yr Ago) | 25.25 | $7.07 |
| 1 Yrs Avg-PE | 25.25 | $7.07 |
| Value-Trades Assigned | 17.5 | $4.90 |
Note: Only 1 years of reliable P/E data available. Fair value is calculated using blended models to reduce bias.
